About Our Group About Our Group

Our Businesses Our Businesses

Investor Relations Investor Relations

Sustainability Sustainability

Otsuka Group News

HOME
Otsuka Group News

Keyword search

Add search criteria

Search by company

Otsuka Holdings
Otsuka Pharmaceutical
Otsuka Pharmaceutical Factory
Taiho Pharmaceutical
Otsuka Warehouse
Otsuka Chemical
Otsuka Foods
Otsuka Medical Devices
Other

Search by category^*

Pharmaceuticals Business
Nutraceuticals Business
Consumer Products Business
Others
Products
R&D
Personnel
Corporate

* Business categories are based on the business segments described in the financial announcements.

Search by release date

-

Showing 13 results

Search by release date:: Jan, 2026 ～ Dec, 2026

February 9, 2026
Otsuka Foods

Otsuka Foods to Release “Health-Conscious Bon Curry with Full Serving of Japan-Grown Vegetables” Single Box Addresses Multiple Dietary Concerns Also Serves as Emergency Food That Does Not Require Heating Free of 28 Allergens, Gluten-Free, and Made Without Animal-Based Ingredients
February 9, 2026
Otsuka Foods

Otsuka Foods to Release “Bon Curry NEO Smoky Beef Curry: Hot” Deep, Sophisticated Flavor Combines Roasted Spices and Rich Sauce In Stores across Japan from March 2, 2026
February 6, 2026
Otsuka Pharmaceutical

Otsuka Enters into Agreement with South Korea-based Sky Labs for Exclusive Commercialization Rights in Japan to the Automated Blood Pressure Monitor CART BP pro -First-in-world ring type blood pressure monitor that has received regulatory approval and insurance reimbursement in South Korea-
February 5, 2026
Otsuka Pharmaceutical

Tianjin Otsuka Beverage Opens New POCARI SWEAT Factory New facility to serve as a “health awareness hub”
January 27, 2026
Otsuka Pharmaceutical

Otsuka Announces FDA Acceptance and Priority Review of New Drug Application for Centanafadine for the Treatment of ADHD in Children, Adolescents, and Adults
January 26, 2026
Otsuka Pharmaceutical

Otsuka Pharmaceutical Begins Rollout of PET Bottles Made from 100% Recycled PET Resin Aiming to Realize a Decarbonized and Circular Society
January 21, 2026
Otsuka Pharmaceutical

Otsuka and Towa Conclude Basic Agreement on the Succession and Manufacturing Outsourcing of Long Listed Products, Establishing a Collaborative Framework for Stable Supply
January 21, 2026
Otsuka Pharmaceutical

Dawnzera (donidalorsen) granted European Union marketing authorisation for the prevention of hereditary angioedema
January 19, 2026
Otsuka Pharmaceutical

Otsuka Pharmaceutical and Dr. Keisuke Kataoka of the National Cancer Center Japan and Keio University Receive the Minister of Education, Culture, Sports, Science and Technology Award for Development of Gene Panel Test for Hematological Malignancies
January 19, 2026
Otsuka Pharmaceutical

Otsuka Pharmaceutical Expands On-Site Solar Power Facilities at Factory Premises Accelerating Carbon-Neutral Initiatives
January 14, 2026
Otsuka Holdings

Otsuka Holdings Submits Commitment Letter to Obtain Science-Based Targets Validation for the Entire Otsuka Group
January 6, 2026
Otsuka Holdings

Otsuka Group Introduces Wind Power Derived Electricity as “Self-Generated Renewable Energy” to Promote Carbon Neutrality Initiatives
January 5, 2026
Taiho Pharmaceutical

Sanofi and Taiho Announce Sales Transfer of Anticancer Agent JEVTANA® Intravenous Infusion 60 mg

Otsuka Group News

HOME
Otsuka Group News